Sirtex Medical Limited Given Reduce Rating at CIMB (SRX)
Sirtex Medical Limited (ASX:SRX)‘s stock had its “reduce” rating reaffirmed by investment analysts at CIMB in a note issued to investors on Friday, American Banking & Market News reports.
Shares of Sirtex Medical Limited (ASX:SRX) remained flat at A$14.000 during during mid-day trading trading on Friday. 112,788 shares of the company’s stock traded hands. Sirtex Medical Limited has a 52 week low of A$9.360 and a 52 week high of A$14.590. The stock has a 50-day moving average of A$12.00 and a 200-day moving average of A$12.42. The company has a market cap of A$785.1 million and a P/E ratio of 43.75.
Sirtex Medical Limited is a biotechnology and medical device company. The Company is engaged in manufacturing and to distribute liver cancer treatments utilizing particle technology to approved markets in Asia-Pacific, Europe and the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.